Zubareva N.A.

Latest

• Antimicrobial susceptibility of Moraxella catarrhalis in Russia: results of the PEGAS 2010–2021 multicenter study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(2):188-193

• Aztreonam: clinical and pharmacological characteristics at the present stage

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):19-25

• Review of the international consensus guidelines for the optimal use of the polymyxins

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):282-309

• Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study ”MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):171-180

• Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):160-170

• Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):147-159

• Review of updated clinical practice guidelines of the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) for Clostridium difficile infection in adults and children (2017)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(2):76-124

• Topical therapy of wound infections: antiseptics or antibiotics?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):131-138

• Evidence Based Review on Daptomycin Use in the Treatment of Gram(+) Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(4):270-281

• Genotyping Analysis of Nosocomial Acinetobacter baumannii Strains

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(4):297-300

• Telavancin — New Antimicrobial Active Against Multiresistant Gram-Positive Pathogens. Clinical and Microbiological Features in Questions and Answers

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(2):127-145

• Systemic Antimicrobials Consumption and Expenditures in Intensive Care Units of Hospitals in Russian Federation and Republic of Belarus: Results of Multicenter Pharmacoepidemiological Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):294-311

• Comparative Efficacy of Topical Combination of Bacitracin and Neomycin vs. Chloramphenicol in the Treatment of Uncomplicated Mild to Moderate Surgical Skin and Soft Tissue Infections in Adult Out-patients

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):131-142

• Systemic Antimicrobials Consumption and Expenditures in Multi-Profile Hospitals in Russian Federation and Republic of Belarus: the Results of Multicenter Pharmacoepidemiological Trial

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(4):322-341